Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma.

ABSTRACT:

SUBMITTER: Allmeroth K 

PROVIDER: S-EPMC7932915 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature